A AMGN

AMGEN Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Amgen Inc. is a leading multinational biopharmaceutical company headquartered in Thousand Oaks, California, recognized for its pioneering therapies developed through recombinant DNA technology. The company focuses on key therapeutic areas including oncology, nephrology, and inflammation, utilizing i...

$338.02

-0.46% ($1.55)

Volume 2.50M

52W High $391.29

52W Low $255.28

Market Cap $149.09B

← Back to Calendar Compare with Others →

Next Earnings Report

No earnings data available for AMGN

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q4 2025 Feb 2, 2026

1-Day: -1.77%

Q3 2025 Oct 29, 2025

1-Day: +0.08%

5-Day: +1.55%

Q2 2025 Aug 5, 2025

1-Day: -5.14%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$9.90B	+8.9%	81.9%	39.8%	$1.33B
Q3'25	$9.56B	+12.4%	67.8%	26.4%	$3.22B
Q2'25	$9.17B	+9.3%	67.2%	28.8%	$1.43B
Q1'25	$8.15B	+9.4%	63.6%	14.5%	$1.73B
Q4'24	$9.09B	+10.9%	65.8%	25.4%	$627.0M
Q3'24	$8.50B	+23.2%	61.1%	24.1%	$2.83B
Q2'24	$8.39B	+20.1%	61.4%	22.8%	$746.0M
Q1'24	$7.45B	+22.0%	57.0%	13.3%	-$113.0M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	Apr 29, 2026	$5.16	$5.54	--	--	--
Q4 2025	Feb 2, 2026	$4.72	$5.03	$5.29	+12.08%	Beat
Q3 2025	Oct 29, 2025	$5.02	$5.34	$5.64	+12.35%	Beat
Q2 2025	Aug 5, 2025	$5.28	$5.53	$6.02	+14.02%	Beat
Q1 2025	May 1, 2025	$4.26	$4.44	$4.90	+15.02%	Beat
Q4 2024	Feb 4, 2025	$5.08	$5.19	$5.31	+4.53%	Beat
Q3 2024	Oct 30, 2024	$5.11	$5.29	$5.58	+9.20%	Beat
Q2 2024	Aug 6, 2024	$5.01	$5.25	$4.97	-0.80%	Missed
Q1 2024	May 2, 2024	$3.87	$4.02	$3.96	+2.33%	Missed
Q4 2023	Feb 6, 2024	$4.61	$4.85	$4.71	+2.17%	Missed
Q3 2023	Oct 31, 2023	$4.67	$4.85	$4.96	+6.21%	Beat
Q2 2023	Aug 3, 2023	$4.49	$4.60	$5.00	+11.36%	Beat